Survivorship

Abstract

Survivorship, which the scientific indexing vocabulary files under emotional adjustment within psychological adaptation, is the lived experience of adjusting to life after a diagnosis of a potentially life-threatening illness, most often cancer. Cognitive psychology treats it as a problem of appraisal: what shapes a survivor's adjustment is less the medical facts than how the person interprets an ambiguous body, an uncertain future, and a changed sense of self. This article traces the construct from Mullan's seasons of survival, through the psychosocial burden and late effects that outlast treatment, to the fear of recurrence that is survivorship's signature cognitive challenge, and on to the resilience and posttraumatic growth that commonly follow. Across these literatures survivorship emerges not as a medical endpoint but as an ongoing, appraisal-driven adaptation to having survived.

Keywords: survivorship, cancer survivor, fear of recurrence, adaptation, posttraumatic growth

Survivorship denotes the processes by which a person adjusts cognition, emotion, and behavior to life after the diagnosis and treatment of a potentially life-threatening disease. The scientific indexing vocabulary places it beneath emotional adjustment, itself a subtype of psychological adaptation, reflecting that survivorship is fundamentally a problem of adjustment rather than of medicine: the disease may be controlled while the task of living with its aftermath has only begun. Mullan (1985), a physician writing about his own cancer, gave the field its founding image when he described survival not as a single moment of cure but as a sequence of seasons, each with its own psychological demands. The literatures surveyed here elaborate a single question that follows from that image: once a person has survived, what turns the ambiguity of a changed body and an uncertain future into an adjustment that holds or fails?

What Survivorship Is

Survivorship is the set of processes through which a person manages the relationship between themselves and a life that has been reorganized around having survived a serious illness. The usage that shaped the field comes from oncology, where the National Coalition for Cancer Survivorship advanced the position that a person is a survivor from the moment of diagnosis through the balance of life, a deliberately broad definition that refuses to make survivorship begin only at cure. Survivorship in this sense is a form of emotional adjustment: the medical event sets the demand, but the adjustment is psychological, turning on how the person appraises what the illness means for their body, their relationships, their plans, and their sense of who they are.

The influential Institute of Medicine report (Hewitt, Greenfield, & Stovall, 2006), From Cancer Patient to Cancer Survivor: Lost in Transition, named the structural problem at the center of survivorship: a care system organized around diagnosis and treatment leaves survivors without a map for the period after active treatment ends, so that the transition out of treatment is often experienced as being abandoned rather than cured. Its central remedy was the survivorship care plan, a written summary of the treatment received and a forward plan for surveillance and the management of late effects, intended to give the survivor and their clinicians the map that the transition out of active care had been missing. Feuerstein (2007), founding editor of the field's journal, pressed for a working definition spanning the physical, psychological, social, and economic dimensions of life after diagnosis, so that survivorship research would address the whole person rather than the disease alone. What unifies these efforts is a relational framing: survivorship is not a medical status conferred by a clean scan but a continuously negotiated adjustment to having a cancer history.

Seasons of Survival

The organizing image of survivorship is Mullan's (1985) seasons of survival. Writing as a physician living with his own cancer, Mullan argued that survival is not a single event but a passage through distinct stages, each posing its own psychological and medical demands. Acute survival begins at diagnosis and is dominated by the immediate threat of the disease and the toxicity of treatment, with fear and the mechanics of medical crisis in the foreground. Extended survival follows the end of initial treatment, a period he characterized by watchful waiting, intermittent therapy, and the pervasive fear of recurrence that colors the return to ordinary life. Permanent survival approximates what is loosely called cure: the likelihood of recurrence recedes, but the person carries the long-term and late effects of the disease and its treatment, along with a permanently altered relationship to health.

The power of the seasons framing is that it makes survivorship a trajectory rather than a status, and it predicts that the content of adjustment changes over time even as the person remains, throughout, a survivor. The concerns that dominate acute survival give way to the surveillance and recurrence worries of extended survival, which in turn give way to the identity, late-effect, and meaning questions of permanent survival. Aziz and Rowland (2003), reviewing the emerging science, used precisely this longitudinal logic to argue that survivorship research must follow survivors across the arc of the illness and beyond, because the needs measured at one season poorly predict those of another. The demonstration below traces how the dominant concerns of survivorship shift as a person moves through Mullan's seasons.

The timeline makes explicit what the seasons model claims: survivorship is not a flat plateau after treatment but a sequence in which the salient demand migrates from the acute burden of treatment, through the recurrence vigilance of reentry, to the late effects and identity work of long-term survival. A survivor is not finished adjusting when treatment ends; they have entered a different season of the same adjustment.

The Psychosocial Burden and Late Effects

Survivorship carries a psychosocial burden that outlasts the disease. Stein, Syrjala, and Andrykowski (2008) catalogued the physical and psychological long-term and late effects of cancer, drawing the crucial distinction between long-term effects, which begin during treatment and persist, and late effects, which appear months or years after treatment has ended. Fatigue, pain, cognitive complaints, sexual dysfunction, and elevated anxiety and depression are common and frequently under-treated, because a care system focused on disease control is poorly configured to detect problems that surface after the patient has left active oncology care.

The psychological consequences are not merely a shadow of the physical ones. Stanton (2006) reviewed the psychosocial concerns of cancer survivors and the interventions designed to address them, noting that distress often rises at the end of treatment, precisely when a naive expectation would predict relief, because the structure and reassurance of active care are withdrawn at the moment the survivor must resume an ordinary life they no longer trust. Jacobsen and Jim (2008) assessed the evidence for psychosocial interventions targeting anxiety and depression in adult cancer patients, finding genuine but uneven benefits and arguing for better matching of intervention intensity to the survivor's actual level of need rather than offering the same support to everyone. The recurring theme is a mismatch between a biomedical model that measures success by disease control and a survivor whose adjustment is governed by how they appraise a body and a future that medicine has made safer but not certain.

Fear of Cancer Recurrence

The signature cognitive challenge of survivorship is the fear of cancer recurrence. Simard and colleagues (2013) systematically reviewed the quantitative literature and found fear of recurrence to be among the most common and persistent unmet needs of survivors, affecting a substantial majority to some degree and a large minority severely, with little tendency to fade spontaneously over time. Lebel and colleagues (2016) moved the construct from a normal worry to a defined clinical problem, proposing consensus criteria that distinguish ordinary, adaptive vigilance from clinical fear of recurrence marked by high preoccupation, persistent intrusive thoughts, hypervigilance to bodily sensations, functional impairment, and difficulty planning for the future.

Fear of recurrence is illuminating for cognitive psychology because it is transparently an appraisal phenomenon. Two survivors with identical medical prognoses can experience entirely different levels of fear, because fear tracks not the objective probability of recurrence but the person's perceived probability, the perceived severity of a recurrence, and their perceived ability to cope with the threat and its uncertainty. The mechanism is a misappraisal of ambiguous internal signals: a headache, an ache, or ordinary fatigue, which before illness would have passed unnoticed, is now appraised as a possible sign of returning disease, triggering the vigilance and checking that maintain the fear. The Worked Example below formalizes this appraisal as a simple multiplicative rule, and the demonstration that follows lets the three appraisals be varied independently.

Figure 1

The Appraisal Model of Fear of Cancer Recurrence

The demonstration makes the appraisal structure explicit: raising perceived control over the threat lowers fear even when perceived risk is held fixed, which is why interventions for fear of recurrence work on the appraisal (building tolerance of uncertainty and a sense of agency) rather than on the medical facts, which are usually not in the survivor's power to change.

Adaptation, Resilience, and Growth

For all its burdens, survivorship is not predominantly a story of damage. The resilience literature, developed on bereavement and potential trauma, applies directly: Bonanno (2004) showed that a stable trajectory of healthy functioning is the modal response to aversive events, not a sign of denial, and survivorship research has repeatedly found that most survivors adjust well over time without developing a clinical disorder. Where distress persists, it is often concentrated in an identifiable minority, which is the empirical basis for the risk-stratified, intensity-matched care that Jacobsen and Jim (2008) called for.

Many survivors report change in a positive direction. Tedeschi and Calhoun (1996) named and operationalized posttraumatic growth with their inventory, measuring reported positive change in relating to others, new possibilities, personal strength, spiritual life, and appreciation of life, and cancer survivorship is among the contexts in which such growth is most consistently reported. The crucial point, and a common misreading, is that growth arises from the struggle with the illness rather than from the illness being benign, so that reported growth coexists with continuing distress rather than replacing it. Folkman and Moskowitz (2004) made the parallel case for coping, documenting that positive emotion can be generated and sustained in the midst of chronic stress and serves its own adaptive function alongside the reduction of distress, which is exactly the pattern survivors describe.

Synthesizing the psycho-oncology evidence, Stanton, Rowland, and Ganz (2015) argued that life after cancer is best understood through the same appraisal-and-coping framework that organizes psychological adaptation generally: survivors who find meaning in the experience, retain or rebuild a sense of mastery, and draw on social and personal resources adjust better, while those whose appraisals leave them feeling endangered and helpless are the ones who struggle. Survivorship, on this view, is not a special psychology but the general science of adaptation applied to a particular and increasingly common demand.

Worked Example

Consider the appraisal account of fear of cancer recurrence from the demonstration above, expressed as a simple multiplicative rule. Let p be the survivor's perceived probability that the cancer will return, scaled from 0 to 1; let s be the perceived severity of a recurrence, from 0 to 1; and let c be the survivor's perceived control, their confidence that they could cope with the threat and its uncertainty, from 0 (no control) to 1 (full control). Model the intensity of fear as F = p × s × (1 − c), so that fear grows with perceived likelihood and perceived severity but is damped by the sense that one can cope.

Take a survivor who judges recurrence moderately likely, p = 0.5, views it as highly severe, s = 0.8, and feels a middling sense of control, c = 0.5. Their fear is F = 0.5 × 0.8 × (1 − 0.5) = 0.5 × 0.8 × 0.5 = 0.20. Now suppose surveillance scans raise their perceived risk to p = 0.8 while severity and control are unchanged: F = 0.8 × 0.8 × 0.5 = 0.32, a sharp rise driven entirely by the changed appraisal of likelihood. If, in addition, the uncertainty erodes their sense of coping to c = 0.2, fear climbs to F = 0.8 × 0.8 × (1 − 0.2) = 0.8 × 0.8 × 0.8 = 0.512. Conversely, an intervention that builds tolerance of uncertainty and raises perceived control to c = 0.8, holding the frightening appraisals of risk and severity fixed, cuts fear to F = 0.8 × 0.8 × 0.2 = 0.128. The lesson the rule captures is the central empirical regularity of the fear-of-recurrence literature: because the medical facts (p and s as the body presents them) are largely outside the survivor's power to change, the adjustable term is perceived control, which is why effective treatment works on appraisal rather than on reassurance about the odds.

Discussion

The accounts surveyed here form a connected argument rather than a list of separate findings. Mullan's seasons established that survivorship is a trajectory whose demands shift over time; the burden-and-late-effects literature specified what those demands are and showed that they are routinely under-recognized by disease-focused care; the fear-of-recurrence literature isolated survivorship's signature cognitive problem and showed it to be an appraisal phenomenon rather than a rational reading of the odds; and the resilience and growth literatures showed that most survivors adapt well, and many grow, through the same appraisal-and-coping processes that govern psychological adaptation in general. Each layer keeps the relational premise of the last: survivorship is produced not by the medical facts alone but by how a person appraises a life lived after them.

This is why survivorship sits where it does in the behavioral classification, as a form of emotional adjustment beneath psychological adaptation. It is not a separate subject that happens to be filed with adjustment but a particular, high-stakes instance of it, in which the demand is the permanent fact of having had a life-threatening disease and the adjustment is the work of living with an altered body, an uncertain future, and a changed self. The field's open problems, which survivor populations have made urgent, define the directions below.

Current Directions

The most consequential current is demographic: survivor populations are growing rapidly and aging. Miller and colleagues (2022) estimated more than eighteen million cancer survivors in the United States and projected continued growth driven by earlier detection, more effective treatment, and an aging population, so that survivorship is becoming a mass experience rather than a specialist concern. Bluethmann, Mariotto, and Rowland (2016) anticipated a silver tsunami, projecting that the majority of survivors will soon be older adults carrying substantial comorbidity, which compounds the late effects of cancer with the burdens of aging and strains a care system not built for it. Rowland and Bellizzi (2014) had already drawn out what this aging survivor population means for care, arguing that life after treatment must be managed against the backdrop of the comorbidities and functional decline that accumulate with age rather than as a cancer problem in isolation. The demonstration below projects this growth and the shifting age composition that accompanies it.

A second current turns toward redesigning care to meet that scale. Shapiro (2018) reviewed the state of cancer survivorship for clinicians, emphasizing the systematic management of long-term and late effects and the need to integrate survivorship into routine oncology rather than treating it as an afterthought. Jefford and colleagues (2022) set out improved models of survivorship care, arguing for risk-stratified pathways that concentrate specialist resources on the survivors who need them while supporting the well-adjusted majority through less intensive, often primary-care-based follow-up. Across these lines the direction is the same: to match the psychological science of survivorship, which locates adjustment in appraisal and coping, to a care system large and flexible enough to serve a survivor population now counted in the tens of millions.

Common Misconceptions

Survivorship begins only once a person is declared cured.

The influential definition holds that a person is a survivor from the moment of diagnosis through the balance of life, and the seasons model treats survival as a trajectory with demands at every stage, not a status conferred at cure (Mullan, 1985; Hewitt, Greenfield, & Stovall, 2006).

The end of treatment is when distress is lowest.

Distress frequently rises at the end of treatment, when the structure and reassurance of active care are withdrawn and the survivor must resume an ordinary life amid continuing uncertainty (Stanton, 2006).

Fear of recurrence tracks the real odds of the cancer returning.

Fear tracks perceived probability, perceived severity, and perceived ability to cope, not the objective prognosis, so survivors with identical medical odds can differ sharply in fear (Simard et al., 2013; Lebel et al., 2016).

Posttraumatic growth means the survivor is no longer distressed.

Growth arises from the struggle with the illness and coexists with continuing distress rather than replacing it; reporting growth is not evidence that a survivor has stopped suffering (Tedeschi & Calhoun, 1996).

Glossary

Acute survival.

The season beginning at diagnosis, dominated by the immediate threat of the disease and the burden of treatment.

Cancer survivor.

A person living with a history of cancer, under the broad definition from the moment of diagnosis through the balance of life.

Cognitive appraisal.

The interpretive evaluation of what a situation means for one's well-being and what can be done about it; in survivorship it is what turns an ambiguous body and an uncertain future into adjustment or distress.

Extended survival.

The season after initial treatment, characterized by watchful waiting, surveillance, and the fear of recurrence.

Fear of cancer recurrence.

Survivorship's signature cognitive challenge: fear, worry, or preoccupation that the cancer will return, driven by appraisal rather than by objective prognosis.

Late effects.

Consequences of cancer or its treatment that appear months or years after treatment has ended, often under-recognized by disease-focused care.

Long-term effects.

Consequences of cancer or its treatment that begin during treatment and persist afterward, such as chronic fatigue or pain.

Permanent survival.

The season approximating cure, in which recurrence risk recedes but long-term and late effects and an altered identity persist.

Posttraumatic growth.

Positive psychological change arising from the struggle with a highly challenging experience, commonly reported by survivors alongside continuing distress.

Psychosocial oncology.

The field studying and treating the psychological, social, and behavioral dimensions of cancer and survivorship.

Resilience.

The maintenance of a stable trajectory of healthy functioning in the face of adversity; the common rather than the rare survivor outcome.

Seasons of survival.

Mullan's model of survival as a passage through distinct stages (acute, extended, and permanent), each with its own psychological and medical demands.

Survivorship care plan.

A document summarizing a survivor's treatment and a plan for follow-up, surveillance, and management of late effects, proposed to address the lost-in-transition gap.

Survivorship.

The ongoing psychological adjustment to life after the diagnosis and treatment of a potentially life-threatening disease, most often cancer.

Key Researchers

Catherine M. Alfano

. Cancer-survivorship researcher who has held survivorship leadership roles at the American Cancer Society and Northwell Health and now at Oncovery Care; works on models of survivorship care delivery and the integration of survivorship into oncology practice. Google Scholar

Michael Feuerstein

. Clinical health psychologist and professor emeritus at the Uniformed Services University of the Health Sciences; founding editor-in-chief of the Journal of Cancer Survivorship, who pressed for a working definition of survivorship spanning its physical, psychological, social, and economic dimensions. Google Scholar

Patricia A. Ganz

. Distinguished professor at the University of California, Los Angeles; a founder of cancer-survivorship and quality-of-life research, mapping the long-term physical and psychosocial sequelae of treatment and the needs of survivors after active care ends. ORCID - Google Scholar - Wikipedia - Wikidata

Sophie Lebel

. Professor in the School of Psychology at the University of Ottawa; a leader in research on fear of cancer recurrence, helping define it as a distinct clinical problem and building the conceptual and treatment framework that survivorship care now uses. ORCID - Google Scholar - Faculty Page

Fitzhugh Mullan

(1942-2019). Physician, writer, and health-policy scholar at George Washington University; coined the “seasons of survival” in his 1985 essay, recasting survival as a lived trajectory rather than a binary outcome, and founded the National Coalition for Cancer Survivorship. Wikipedia - Wikidata

Julia H. Rowland

. Psychologist and founding director of the NCI Office of Cancer Survivorship from 1999 to 2017, now senior strategic advisor at the Smith Center for Healing and the Arts; shaped the national research agenda on life after cancer treatment and the growing survivor population. Faculty Page

Annette L. Stanton

. Distinguished research professor of psychology at the University of California, Los Angeles; studies psychosocial adjustment and coping in cancer survivors, including the role of emotional approach coping and the benefits and limits of psychosocial interventions after treatment. Faculty Page

Frequently Asked Questions

What is survivorship?

It is the ongoing psychological adjustment to life after the diagnosis and treatment of a potentially life-threatening disease, most often cancer; in the behavioral classification it is a form of emotional adjustment, concerned with how a person adapts to living after a serious illness rather than with the disease itself (Feuerstein, 2007).

When does cancer survivorship begin?

Under the broad and now widely adopted definition, a person is a survivor from the moment of diagnosis through the balance of life, not only once they are declared cured; the seasons model similarly treats survival as a trajectory with demands at every stage (Mullan, 1985).

What are Mullan's seasons of survival?

Three stages, each with its own demands: acute survival, dominated by diagnosis and treatment; extended survival, marked by watchful waiting and fear of recurrence; and permanent survival, approximating cure while carrying long-term and late effects (Mullan, 1985).

What is the difference between long-term effects and late effects?

Long-term effects begin during treatment and persist afterward, whereas late effects appear months or years after treatment has ended; both are common and frequently under-recognized by care focused on disease control (Stein, Syrjala, & Andrykowski, 2008).

What is fear of cancer recurrence?

It is survivorship's most common persistent concern: fear or preoccupation that the cancer will return, which becomes a clinical problem when it is marked by high preoccupation, intrusive thoughts, hypervigilance to bodily sensations, and functional impairment (Simard et al., 2013; Lebel et al., 2016).

Why do two survivors with the same prognosis fear recurrence differently?

Because fear tracks appraisal, not the objective odds: it rises with the perceived probability and perceived severity of a recurrence and falls with the survivor's perceived ability to cope, so the same medical facts produce different fear depending on how they are interpreted (Lebel et al., 2016).

Do most cancer survivors develop lasting psychological problems?

No; resilience is the common outcome, and persistent distress is concentrated in an identifiable minority, which is the basis for risk-stratified, intensity-matched survivorship care (Bonanno, 2004; Jacobsen & Jim, 2008).

Can survivors experience positive change?

Yes; many survivors report posttraumatic growth in relationships, perceived strength, priorities, and appreciation of life, arising from the struggle with the illness and coexisting with continuing distress rather than replacing it (Tedeschi & Calhoun, 1996).

References